Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value

MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma

(2012) Jian Wang et al.   BMC CANCER

miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer

(2012) J Zhang et al.   BRITISH JOURNAL OF CANCER

MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma

(2012) Wei-Qing Kong et al.   FEBS Journal

MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma

(2012) Zhaojian Liu et al.   JOURNAL OF PATHOLOGY

A Facile and Specific Assay for Quantifying MicroRNA by an Optimized RT-qPCR Approach

(2012) Qian Mei et al.   PLoS One

microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2

(2011) Jing Nie et al.   CARCINOGENESIS

miR-182 as a Prognostic Marker for Glioma Progression and Patient Survival

(2010) Lili Jiang et al.   AMERICAN JOURNAL OF PATHOLOGY

Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro

(2010) Yihua Sun et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states

(2009) Aaron L Sarver et al.   BMC CANCER

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

(2009) E K O Ng et al.   GUT

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

(2009) Miguel F. Segura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma

(2008) Aaron J. Schetter et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION